Cote d'Ivoire vs Cuba: Antiretroviral therapy coverage for PMTCT
Cote d'Ivoire
88.0%
in 2024
Cuba
89.0%
in 2024
Cote d'Ivoire rank
31st
Cuba rank
30th
Antiretroviral therapy coverage for PMTCT over time
- Cote d'Ivoire
- Cuba
How they compare
Cuba currently reports 89.0% against 88.0% in Cote d'Ivoire, a difference of 1.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Cuba ahead.
Cote d'Ivoire ranks 31st and Cuba ranks 30th of 84 countries.
Across the 3 decades both report, Cote d'Ivoire averaged higher in 1 and Cuba in 2.
Head to head by decade
| Decade | Cote d'Ivoire | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 36.4% | 23.4% | Cuba |
| 2010s | 75.3% | 73.9% | 1.4% | Cote d'Ivoire |
| 2020s | 90.6% | 97.6% | 7.0% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Cote d'Ivoire or Cuba?
- Cuba, at 89.0% against 88.0% in Cote d'Ivoire as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Cote d'Ivoire and Cuba?
- 1.0%, with Cuba ahead.
- How many years of comparable data are there for Cote d'Ivoire and Cuba?
- 25 years are reported by both, from 2000 to 2024.
- How do Cote d'Ivoire and Cuba rank globally for antiretroviral therapy coverage for pmtct?
- Cote d'Ivoire ranks 31st and Cuba ranks 30th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).